Literature DB >> 27247352

Developing New, Rational Therapies for Recalcitrant Small Cell Lung Cancer.

Adi F Gazdar1, John D Minna2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27247352     DOI： 10.1093/jnci/djw119

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  9 in total

1.  Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse.

Authors:  Karinna Almodovar; Wade T Iams; Catherine B Meador; Zhiguo Zhao; Sally York; Leora Horn; Yingjun Yan; Jennifer Hernandez; Heidi Chen; Yu Shyr; Lee P Lim; Christopher K Raymond; Christine M Lovly
Journal:  J Thorac Oncol       Date:  2017-09-23       Impact factor: 15.609

2.  Improved Prognosis and Increased Tumor-Infiltrating Lymphocytes in Patients Who Have SCLC With Neurologic Paraneoplastic Syndromes.

Authors:  Wade T Iams; Eileen Shiuan; Catherine B Meador; Marc Roth; Jennifer Bordeaux; Christine Vaupel; Kelli L Boyd; IlaSri B Summitt; Lucy L Wang; Joseph T Schneider; Jeremy L Warner; Zhiguo Zhao; Christine M Lovly
Journal:  J Thorac Oncol       Date:  2019-06-12       Impact factor: 15.609

Review 3.  Immunotherapeutic approaches for small-cell lung cancer.

Authors:  Wade T Iams; Jason Porter; Leora Horn
Journal:  Nat Rev Clin Oncol       Date:  2020-02-13       Impact factor: 66.675

4.  A step towards valid detection and quantification of lung cancer volume in experimental mice with contrast agent-based X-ray microtomography.

Authors:  Pidassa Bidola; Juliana Martins de Souza E Silva; Klaus Achterhold; Enkhtsetseg Munkhbaatar; Philipp J Jost; Anna-Lena Meinhardt; Kirsten Taphorn; Marie-Christine Zdora; Franz Pfeiffer; Julia Herzen
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

5.  A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer.

Authors:  Masahito Shimojo; Yuuya Kasahara; Masaki Inoue; Shin-Ichi Tsunoda; Yoshie Shudo; Takayasu Kurata; Satoshi Obika
Journal:  Sci Rep       Date:  2019-05-20       Impact factor: 4.379

6.  An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer.

Authors:  Zhihui Zhang; Yuejun Luo; Chaoqi Zhang; Peng Wu; Guochao Zhang; Qingpeg Zeng; Lide Wang; Liyan Xue; Zhaoyang Yang; Hua Zeng; Bo Zheng; Fengwei Tan; Qi Xue; Shugeng Gao; Nan Sun; Jie He
Journal:  Cancer Cell Int       Date:  2021-12-20       Impact factor: 5.722

7.  m6A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer.

Authors:  Zhihui Zhang; Chaoqi Zhang; Yuejun Luo; Peng Wu; Guochao Zhang; Qingpeng Zeng; Lide Wang; Zhaoyang Yang; Liyan Xue; Bo Zheng; Hua Zeng; Fengwei Tan; Qi Xue; Shugeng Gao; Nan Sun; Jie He
Journal:  BMC Med       Date:  2021-11-22       Impact factor: 8.775

8.  Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer.

Authors:  Yanhua Tian; Qingqing Li; Zhenlin Yang; Shu Zhang; Jiachen Xu; Zhijie Wang; Hua Bai; Jianchun Duan; Bo Zheng; Wen Li; Yueli Cui; Xin Wang; Rui Wan; Kailun Fei; Jia Zhong; Shugeng Gao; Jie He; Carl M Gay; Jianjun Zhang; Jie Wang; Fuchou Tang
Journal:  Signal Transduct Target Ther       Date:  2022-10-05

Review 9.  What's New in SCLC? A Review.

Authors:  Bryan Oronsky; Tony R Reid; Arnold Oronsky; Corey A Carter
Journal:  Neoplasia       Date:  2017-09-06       Impact factor: 5.715
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.